PARP1 and neoplasm: In addition, PARP inhibition has been shown to upregulate antigen presentation machinery—including MHC class I and TAP1/2—and increase chemokines such as CXCL10 and CCL5, thereby fostering a tumor microenvironment permissive to T-cell recruitment [115,116].